Dynamic Changes of Distinct Compartmental LV Remodeling Following Septal Myectomy in Hypertrophic Obstructive

Xinyi Luo1, Guanyu Lu2, Ziyu Liu3

  • 1Department of Radiology (X.L., Y.C., J.O., R.C., H.L., Y.Y.), Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Insights

Septal myectomy significantly reduces left ventricular mass index (LVMi) in hypertrophic obstructive cardiomyopathy patients. Early reduction involves cellular and extracellular changes, with sustained extracellular remodeling over 24 months.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Biomedical Imaging

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by increased left ventricular mass index (LVMi).
  • Septal myectomy is a surgical intervention for HOCM, leading to LVMi regression.
  • The precise dynamics and mechanisms of LVMi regression post-myectomy remain incompletely understood.

Purpose of the Study:

  • To investigate the temporal changes in LVMi, cellular volume, and extracellular volume after septal myectomy in HOCM patients.
  • To identify factors associated with LVMi regression following the surgical procedure.

Main Methods:

  • Prospective study of 27 HOCM patients undergoing septal myectomy.
  • Cardiac MRI performed preoperatively and at 6, 12, and 24 months postoperatively.
  • Analysis of LVMi, indexed cellular volume, and indexed extracellular volume using repeated measures ANOVA and linear regression.

Main Results:

  • Significant LVMi decrease from baseline (105.76±25.22 g/m²) to 76.22±23.93 g/m² at 24 months (P<0.05).
  • Early regression (first 6 months) driven by both cellular (23.70%) and extracellular (18.40%) volume reduction.
  • From 12-24 months, extracellular volume continued to decline (P<0.001), while cellular volume stabilized.
  • Greater reduction in left ventricular outflow tract pressure gradient correlated with LVMi regression (β=0.157; P=0.001).

Conclusions:

  • Early LVMi reduction post-myectomy involves both cellular and extracellular compartments.
  • Slower, sustained regression of extracellular volume occurs between 12 and 24 months, indicating myocardial adaptability to afterload reduction.
  • The degree of left ventricular outflow tract pressure gradient reduction is a key factor associated with LVMi regression after septal myectomy.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22